22 Healthcare Stocks Moving In Tuesday's Pre-Market Session

Gainers

  • AVEO Pharmaceuticals, Inc. AVEO stock moved upwards by 43.0% to $1.01 during Tuesday's pre-market session. The market cap seems to be at $571.7 million.
  • Mesoblast, Inc. MESO stock surged 14.3% to $5.75. The market cap stands at $483.9 million.
  • Mallinckrodt, Inc. MNK shares rose 13.8% to $2.39. The most recent rating by Stifel, on September 09, is at Hold, with a price target of $8.00.
  • Adamis Pharmaceuticals, Inc. ADMP stock surged 8.0% to $0.80. The market value of their outstanding shares is at $66.0 million. According to the most recent rating by B. Riley FBR, on July 23, the current rating is at Neutral.
  • Viveve Medical, Inc. VIVE stock moved upwards by 7.3% to $0.10. According to the most recent rating by Ladenburg Thalmann, on July 24, the current rating is at Neutral.
  • Microbot Medical, Inc. MBOT shares increased by 6.1% to $7.85. The market cap seems to be at $64.5 million. The most recent rating by H.C. Wainwright, on July 22, is at Buy, with a price target of $10.00.
  • Aurinia Pharmaceuticals, Inc. AUPH shares surged 4.8% to $6.08. The most recent rating by Oppenheimer, on September 10, is at Outperform, with a price target of $14.00.
  • Aptose Biosciences, Inc. APTO stock moved upwards by 4.5% to $2.55. The market cap seems to be at $83.0 million. The most recent rating by H.C. Wainwright, on August 07, is at Buy, with a price target of $6.00.

 

Losers

  • Intra-Cellular Therapies, Inc. ITCI shares decreased by 11.4% to $9.15 during Tuesday's pre-market session. The market cap stands at $536.5 million. The most recent rating by Jefferies, on August 12, is at Buy, with a price target of $16.00.
  • Neurotrope, Inc. NTRP stock declined 7.0% to $0.93. The market cap seems to be at $15.4 million. The most recent rating by Janney Capital, on June 18, is at Buy, with a price target of $14.00.
  • SINTX Technologies, Inc. SINT shares declined 6.6% to $1.41. The market value of their outstanding shares is at $6.5 million.
  • DBV Technologies, Inc. DBVT shares fell 5.5% to $8.97. The market cap stands at $1.1 billion. The most recent rating by Goldman Sachs, on June 17, is at Buy, with a price target of $14.00.
  • Cesca Therapeutics, Inc. KOOL shares decreased by 4.9% to $3.90.
  • Intec Pharma, Inc. NTEC shares decreased by 3.6% to $0.87. The market cap stands at $144.5 million. According to the most recent rating by H.C. Wainwright, on August 07, the current rating is at Neutral.
  • AstraZeneca, Inc. AZN stock fell 3.0% to $42.48.
  • GlaxoSmithKline, Inc. GSK shares declined 2.9% to $40.29. The market value of their outstanding shares is at $96.0 billion. According to the most recent rating by Societe Generale, on September 03, the current rating is at Buy.
  • Novo Nordisk, Inc. NVO shares fell 2.8% to $49.28. According to the most recent rating by Jefferies, on August 30, the current rating is at Underperform.
  • Histogenics, Inc. HSGX stock decreased by 2.7% to $0.27. The market value of their outstanding shares is at $52.8 million.
  • Qiagen, Inc. QGEN shares declined 2.6% to $32.58. The market cap seems to be at $800.0 million. According to the most recent rating by Evercore ISI Group, on July 16, the current rating is at In-Line.
  • Cassava Sciences, Inc. SAVA shares fell 2.5% to $1.19. The market cap stands at $14.6 million.
  • Grifols, Inc. GRFS shares plummeted 2.3% to $20.27. The market value of their outstanding shares is at $14.1 billion. The most recent rating by JP Morgan, on June 27, is at Overweight, with a price target of $22.50.
  • Kitov Pharma, Inc. KTOV stock fell 2.0% to $0.84.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsMovers & ShakersPre-Market OutlookMarketsMoversTrading IdeasGeneralHealthcare Stocks Pre-Market MoversTop Gainers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!